{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:25:37Z","timestamp":1790691937278,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01MH063480-12"],"award-info":[{"award-number":["5R01MH063480-12"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5R01MH045817"],"award-info":[{"award-number":["5R01MH045817"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002326","name":"Scioto Foundation","doi-asserted-by":"publisher","award":["07R-1712"],"award-info":[{"award-number":["07R-1712"]}],"id":[{"id":"10.13039\/100002326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pittsburgh Center for Kidney Research Kidney Imaging Core","award":["NIH P30 DK079307"],"award-info":[{"award-number":["NIH P30 DK079307"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.antiviral.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T03:27:56Z","timestamp":1490239676000},"page":"136-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Comparison of three cell-based drug screening platforms for HSV-1 infection"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-2093","authenticated-orcid":false,"given":"Leonardo","family":"D'Aiuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-0220","authenticated-orcid":false,"given":"Kelly","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dimitrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-7588","authenticated-orcid":false,"given":"James","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanti Babu","family":"Dokuburra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-8497","authenticated-orcid":false,"given":"Wen Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Schurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-3376","authenticated-orcid":false,"given":"Joel","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Kinchington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-8494","authenticated-orcid":false,"given":"David C.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-5927","authenticated-orcid":false,"given":"Vishwajit L.","family":"Nimgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.03.016_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/rmv.1740","article-title":"Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics","volume":"23","author":"Antoine","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8","article-title":"In\u00a0vitro and in\u00a0vivo activity of eugenol on human herpesvirus","volume":"14","author":"Benencia","year":"2000","journal-title":"Phytother. Res."},{"key":"10.1016\/j.antiviral.2017.03.016_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jcv.2014.09.001","article-title":"Aciclovir-induced neurotoxicity: utility of CSF and serum CMMG levels in diagnosis","volume":"61","author":"Berry","year":"2014","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib4","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1099\/vir.0.81850-0","article-title":"Neurotropism of herpes simplex virus type 1 in brain organ cultures","volume":"87","author":"Braun","year":"2006","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.antiviral.2013.09.012","article-title":"Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey","volume":"100","author":"Burrel","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.03.016_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-0173(03)00192-9","article-title":"Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review","volume":"43","author":"Carter","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.antiviral.2017.03.016_bib7","article-title":"Acyclovir-induced neurotoxicity: a case report and review of literature","author":"Chowdhury","year":"2014","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.antiviral.2017.03.016_bib8","doi-asserted-by":"crossref","first-page":"e941","DOI":"10.1097\/MJT.0000000000000093","article-title":"Acyclovir-induced neurotoxicity: a case report and review of literature","volume":"23","author":"Chowdhury","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.antiviral.2017.03.016_bib9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/glia.22689","article-title":"Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells","volume":"62","author":"Chucair-Elliott","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.antiviral.2017.03.016_bib10","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1021\/jm990580e","article-title":"Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors","volume":"43","author":"Corbett","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.03.016_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/15476278.2015.1011921","article-title":"Large-scale generation of human iPSC-derived neural stem cells\/early neural progenitor cells and their neuronal differentiation","volume":"10","author":"D'Aiuto","year":"2014","journal-title":"Organogenesis"},{"key":"10.1016\/j.antiviral.2017.03.016_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/schbul\/sbu032","article-title":"Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance","volume":"41","author":"D'Aiuto","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.antiviral.2017.03.016_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/13550289909015812","article-title":"Establishment of a quiescent herpes simplex virus type 1 infection in neurally-differentiated PC12 cells","volume":"5","author":"Danaher","year":"1999","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pediatrneurol.2008.02.005","article-title":"Neuropsychologic outcomes in children with neonatal herpes encephalitis","volume":"38","author":"Engman","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2014.08.013","article-title":"Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France","volume":"111","author":"Frobert","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.03.016_bib16","doi-asserted-by":"crossref","unstructured":"Gilham, D. et\u00a0al. Corrigendum to \u201cRVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I\/HDL and represses pathways that contribute to cardiovascular disease\u201d [Atherosclerosis 247 (2016) 48\u201357]. Atherosclerosis 253, 345, doi:10.1016\/j.atherosclerosis.2016.05.012 (2016).","DOI":"10.1016\/j.atherosclerosis.2016.05.012"},{"key":"10.1016\/j.antiviral.2017.03.016_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ndt\/gfg119","article-title":"High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study","volume":"18","author":"Helld\u00e9n","year":"2003","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.antiviral.2017.03.016_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.antiviral.2013.09.008","article-title":"Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1","volume":"100","author":"Hussin","year":"2013","journal-title":"Antivir. Res."},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2017.03.016_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1099\/0022-1317-79-3-549","article-title":"Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells","volume":"79","author":"Immergluck","year":"1998","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib20","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1016\/j.vaccine.2014.10.002","article-title":"The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine","volume":"32","author":"Kuo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.03.016_bib21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/135965350601100805","article-title":"Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB","volume":"11","author":"La Frazia","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2017.03.016_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/cbdd.12589","article-title":"2-Pyridinyl-4(3H)-quinazolinone: a scaffold for anti-influenza A virus compounds","volume":"86","author":"Liu","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2017.03.016_bib23","doi-asserted-by":"crossref","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","article-title":"Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.03.016_bib24","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1021\/jf502162y","article-title":"Synthesis and antiviral bioactivity of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives","volume":"62","author":"Ma","year":"2014","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.antiviral.2017.03.016_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/431585","article-title":"A\u00a0retrospective, case-control study of acyclovir resistance in herpes simplex virus","volume":"41","author":"Malvy","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.03.016_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00003495-199448030-00009","article-title":"Ganciclovir. An update of its therapeutic use in cytomegalovirus infection","volume":"48","author":"Markham","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2017.03.016_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2015.06.005","article-title":"Broad-spectrum non-nucleoside inhibitors of human herpesviruses","volume":"121","author":"McClain","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.03.016_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acsmedchemlett.5b00318","article-title":"iPSC neuronal assay identifies amaryllidaceae pharmacophore with multiple effects against herpesvirus infections","volume":"7","author":"McNulty","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2017.03.016_bib29","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/JVI.03052-14","article-title":"Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons","volume":"89","author":"Messer","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm749","article-title":"Irradiation induces neural precursor-cell dysfunction","volume":"8","author":"Monje","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2017.03.016_bib31","doi-asserted-by":"crossref","unstructured":"Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. N Engl J Med 326, 213\u2013220, doi:10.1056\/NEJM199201233260401 (1992).","DOI":"10.1056\/NEJM199201233260401"},{"key":"10.1016\/j.antiviral.2017.03.016_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/rmv.1787","article-title":"Antiviral drug resistance in herpesviruses other than cytomegalovirus","volume":"24","author":"Piret","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib33","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(18)83248-3","article-title":"Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate","volume":"264","author":"Reardon","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.03.016_bib34","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/JVI.77.5.3307-3311.2003","article-title":"Entry of herpes simplex virus type 1 into primary sensory neurons in\u00a0vitro is mediated by Nectin-1\/HveC","volume":"77","author":"Richart","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib35","first-page":"1655","article-title":"Isolation and structure determination of a proteasome inhibitory metabolite from a culture of Scytonema hofmanni","volume":"18","author":"Shim","year":"2008","journal-title":"J.\u00a0Microbiol. Biotechnol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.04.002","article-title":"Survey of acyclovir-resistant herpes simplex virus in The Netherlands: prevalence and characterization","volume":"32","author":"Str\u00e1nsk\u00e1","year":"2005","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/13550280009030760","article-title":"The HSV 1 genome in quiescently infected NGF differentiated PC12 cells can not be stimulated by HSV superinfection","volume":"6","author":"Su","year":"2000","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.antiviral.2017.03.016_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jac\/dkq135","article-title":"Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor","volume":"65","author":"Sukla","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:43Z","timestamp":1759062403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217300268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"alternative-id":["S0166354217300268"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.03.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of three cell-based drug screening platforms for HSV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}